BioSpace News Archive

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced that effective January 1, 2020, its long-time President and CEO William H. Carson, M.D. will retire from the company’s operational leadership.

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today reported financial results for the third quarter ended September 30, 2019

Dalrada Health, a wholly-owned subsidiary of Dalrada Financial Corp. (OTC Pink: DFCO), recently announced the appointment of accomplished Physician Scientist, Dr. Payal Keswarpu, to the position of Chief Medical Officer.

RDD Pharma, Ltd. (“RDD”), a company focused on orphan and innovative therapies for gastrointestinal disorders entered into a non-binding letter of intent (“LOI”) to acquire Naia Rare Diseases (“Naia”), a biopharmaceutical company developing drugs for Short Bowel Syndrome (“SBS”) and other rare gastrointestinal diseases

NeoImmuneTech, Inc., a clinical-stage T-cell focused biopharmaceutical company dedicated to expanding the immuno-oncology frontier, today announced the appointment of distinguished research and development thought leaders to a newly formed scientific advisory board (“SAB”).

Fast Track-designated program aims to be first targeted therapy addressing root cause of chronically debilitating rare genetic disease

Risalto Health, a digital health services company transforming the delivery of musculoskeletal (MSK) care, has raised $7M in capital from New York-based Health Catalyst Capital Management (HCCM).

Vedanta Biosciences, a clinical-stage biopharmaceutical company developing a new category of therapies for immune-mediated diseases based on defined bacterial consortia, today announced that Silvia Caballero, Ph.D., who leads Vedanta’s program on multidrug-resistant organisms (MDRO), has been named to the TIME 100 NEXT list.

EpicentRx, Inc., a clinical cancer immunotherapy company targeting both sides of the immune system to deliver cancer treatments with minimal toxicity, announced today that it has raised a $35 million Series D financing using the Silicon Valley based life-science focused investment bank, Biotech Alliances International.

In an effort to help clinicians stay current with the latest advancements in medical imaging, Canon Medical Systems, USA, through an unrestricted educational grant, invites you to expert-led forums at this year’s Radiological Society of North America (RSNA) annual meeting, December 1-7, 2019 in Chicago, IL